gsk201305016k2.htm
FORM 6-K
 
 
SECURITIES AND EXCHANGE COMMISSION

Washington D.C. 20549
 
 
Report of Foreign Issuer
 
 
Pursuant to Rule 13a-16 or 15d-16 of

the Securities Exchange Act of 1934
 
 
 
For period ending May 2013
 
GlaxoSmithKline plc
(Name of registrant)


 
 
980 Great West Road, Brentford, Middlesex, TW8 9GS
(Address of principal executive offices)


 
 
Indicate by check mark whether the registrant files or
will file annual reports under cover Form 20-F or Form 40-F


 
 
Form 20-F x     Form 40-F

 
--

 
Indicate by check mark whether the registrant by furnishing the
information contained in this Form is also thereby furnishing the
information to the Commission pursuant to Rule 12g3-2(b) under the
Securities Exchange Act of 1934.


 
 
Yes      No x
--

 
 
 GlaxoSmithKline plc - Result of AGM
 
GlaxoSmithKline plc (GSK) announces that at its Annual General Meeting (AGM) today, all resolutions were passed by shareholders.
 
GlaxoSmithKline AGM Poll Results
 
The following table shows the votes cast for each resolution:
 
 
Resolution
Total votes for*
%
Total votes against
%
Total votes cast
Votes withheld**
1
Adoption of Directors' Report and Financial Statements
3,713,877,875
98.86
42,764,532
1.14
3,756,642,407
9,313,386
2
Approval of the Remuneration Report
3,528,115,173
94.55
203,482,136
5.45
3,731,597,309
34,358,483
3
Election of Lynn Elsenhans
3,753,666,422
99.90
3,577,765
0.10
3,757,244,187
8,711,607
4
Election of Jing Ulrich
3,753,601,642
99.90
3,623,347
0.10
3,757,224,989
8,730,805
5
Election of Hans Wijers
3,712,833,757
98.82
44,327,830
1.18
3,757,161,587
8,794,257
6
Re-election of  Sir Christopher Gent
3,679,075,355
97.92
78,304,492
2.08
3,757,379,847
8,575,946
7
Re-election of Sir Andrew Witty
3,753,850,300
99.90
3,750,413
0.10
3,757,600,713
8,355,081
8
Re-election of Professor Sir Roy Anderson
3,753,929,716
99.91
3,483,857
0.09
3,757,413,573
8,542,221
9
Re-election of Dr Stephanie Burns
3,749,134,033
99.78
8,228,665
0.22
3,757,362,698
8,592,951
10
Re-election of Stacey Cartwright
3,735,971,985
99.43
21,360,372
0.57
3,757,332,357
8,623,292
11
Re-election of Simon Dingemans
3,749,800,702
99.80
7,359,374
0.20
3,757,160,076
8,795,718
12
Re-election of Judy Lewent
3,746,232,485
99.71
11,060,403
0.29
3,757,292,888
8,662,906
13
Re-election of Sir Deryck Maughan
3,748,191,348
99.76
9,051,199
0.24
3,757,242,547
8,713,247
14
Re-election of Dr Daniel Podolsky
3,754,111,479
99.92
3,157,370
0.08
3,757,268,849
8,686,945
15
Re-election of Dr Moncef Slaoui
3,749,544,391
99.79
7,827,828
0.21
3,757,372,219
8,583,575
16
Re-election of Tom de Swaan
3,674,675,513
97.80
82,485,251
2.20
3,757,160,764
8,795,029
17
Re-election of Sir Robert Wilson
3,753,535,701
99.90
3,775,827
0.10
3,757,311,528
8,644,121
18
Re-appointment of auditors
3,666,492,716
99.23
28,325,186
0.77
3,694,817,902
71,137,746
19
Remuneration of auditors
3,704,254,541
99.35
24,310,742
0.65
3,728,565,283
37,390,510
20
Authority for the company to make donations to political organisations and incur political expenditure
3,659,392,600
97.82
81,529,557
2.18
3,740,922,157
25,033,636
21
Authority to allot shares
3,682,938,519
98.08
72,177,589
1.92
3,755,116,108
10,839,686
22
Disapplication of pre-emption rights***
3,691,777,819
98.38
60,965,026
1.62
3,752,742,845
13,212,949
23
Authority for the company to purchase its own shares***
3,708,862,005
98.71
48,366,624
1.29
3,757,228,629
8,727,165
24
Exemption from statement of senior statutory auditor's name
3,737,291,344
99.55
16,941,270
0.45
3,754,232,614
11,723,180
25
Authorise reduced notice of a general meeting other than an AGM***
3,387,919,216
90.22
367,203,576
9.78
3,755,122,792
10,832,999
 
Notes:
*           Includes discretionary votes.
 
 
**         A vote withheld is not a vote in law and is not counted in the calculation of the proportion of votes "For" or "Against" a resolution.
 
***        Indicates Special Resolutions requiring a 75% majority.
 
Sir Crispin Davis did not stand for re-election as a Director, and has stepped down from the Board with effect from the conclusion of the AGM.
 
The following table provides further relevant information:
 
 
 
 
GlaxoSmithKline's
Thirteenth AGM
(2013)
 
 
GlaxoSmithKline's
Twelfth AGM
(2012)
 
Issued share capital
(excluding Treasury Shares)
4,922,724,518
5,046,404,827
Total votes cast and votes withheld lodged as a % of GSK's issued share capital (excluding Treasury Shares)
76.50%
76.91%
Total shareholder population
144,196
147,408
Total number of proxies lodged
8,931
9,717
% of shareholders who lodged proxies
6.19%
6.59%
Number of shareholders, corporate representatives and proxies who attended the AGM
442
426
 
V A Whyte
Company Secretary
1 May 2013
 
These results will shortly be available on the company's website at www.gsk.com.
 
 
GlaxoSmithKline Enquiries:
      
UK Media enquiries:
David Mawdsley
+44 (0) 20 8047 5502
(London)
 
David Daley
+44 (0) 20 8047 5502
(London)
 
Catherine Hartley
+44 (0) 20 8047 5502
(London)
       
US Media enquiries:
Stephen Rea
+1 215 751 4394
(Philadelphia)
 
Kevin Colgan
+1 919 483 2933
(North Carolina)
 
Melinda Stubbee
+1 919 483 2510
(North Carolina)
 
Mary Anne Rhyne
+1 919 483 0492
(North Carolina)
 
Sarah Alspach
+1 202 715 1048
(Washington, DC)
 
Jennifer Armstrong
+1 215 751 5664
(Philadelphia)
       
Analyst/Investor enquiries:
Ziba Shamsi
+44 (0) 20 8047 3289
(London)
 
Lucy Budd
+ 44 (0) 20 8047 2248
(London)
 
Tom Curry
+ 1 215 751 5419
(Philadelphia)
 
Gary Davies
+ 44 (0) 20 8047 5503
(London)
 
James Dodwell
+ 44 (0) 20 8047 2406
(London)
 

 
 
  
SIGNATURES
 
 
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorised.



 
 
GlaxoSmithKline plc
(Registrant)


Date: May 01,  2013
 
By: VICTORIA WHYTE
------------------
 
 
Victoria Whyte
Authorised Signatory for and on
behalf of GlaxoSmithKline plc